GERMANY: DIABETES, TREATMENT COSTS
Article Abstract:
The World Health Organisation predicts the number of diabetes sufferers worldwide to double by year 2025 from 142mn at present. In Germany, the number of diabetics is growing at an annual rate of 6%. Currently the number of patients is estimated at 5mn to 7mn. German medical insurance funds spend about EUR 9.5bn on the treatment of diabetes II, which accounts for about 8% of the expenditures of the insurers. The costs per patient amount to DM 5,538 per year on average. 27% of the total is accounted for by pharmaceuticals, with insulin accounting for 5% of this and oral anti-diabetics 2%. Novo Nordisk holds 42% of the German human insulin market, Aventis 35%, Lilly Deutschland GmbH 17%, and Berlin Chemie 4%.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
GERMANY: INVESTMENTS BY BIOTEST
Article Abstract:
German Dreieich-based Biotest Pharma GmbH is to build a new fractionating facility for DM 30mn. A sterile filling facility worth DM 25mn is already under construction. With the new fractionating facility and a modified fractionating technology, Biotest will be able to increase blood plasma processing by up to 50%, at the same time cutting costs and improving quality. Production start is scheduled for end 2001, when the European approval of the preparations is expected.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
GERMANY: INSULIN PRODUCTION BY DIABEL
Article Abstract:
Diabel Operations, a joint venture of Aventis Pharma and Heinrich Mack Nachf. GmbH & Co KG, has brought on stream a large insulin plant (LIP) at the Hoechst chemical site in Frankfurt. Thus Aventis Pharma Deutschland GmbH hived off its insulin unit.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: GERMANY: ACORDIS HIVES OFF LOGISTICS. GERMANY: CONSTRUCTION CHEMICALS R&D BY SKW. GERMANY: LOGISTICS INVESTMENT BY BASF
- Abstracts: GERMANY: NEW COATING TECHNOLOGY BY BASF. GERMANY: ACRYLIC DISPERSION INVESTMENT BY BASF. GERMANY: HERBERTS DIVESTS FURNITURE COATINGS
- Abstracts: GERMANY: MICROM LABORGERATE TO SYBRON. GERMANY: AVENTIS CROPSCIENCE UPS PRODUCTION. US: ENNIS-AGRI-TECH TO GERMAN VTG-LEHNKERING
- Abstracts: GERMANY: FCM PRESENTS 200-MM GAAS WAFER. GERMANY: MICROELECTRONICS R&D WITH MOTOROLA. Germany: FCM cuts staff
- Abstracts: GERMANY: VIANOVA TO SECURE RESINS SUPPLY. GERMANY: BASELL SET TO BUILD HDPE PLANT. TURKEY: ISPOL BOUGHT BY ELASTROGRAN